2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Exercise
6
Counseling
6
Nutrition Assessment
5
Methods
3
Diet Therapy
3
Caloric Restriction
3
Tirzepatide
2
Resistance Training
2
Naltrexone
2
Metformin
2
Megestrol Acetate
2
Exenatide
2
Educational Status
2
Early Intervention, Educational
2
Diet
2
Cognitive Behavioral Therapy
2
Bupropion
2
Blood Specimen Collection
2
sultamicillin
1
semaglutide
1
licogliflozin
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Ursodeoxycholic Acid
1
Urine Specimen Collection
1
Trehalase
1
Tobacco Use Cessation Devices
1
Tablets
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Overweight
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts